Latest Breaking News On - Nuvation bio inc - Page 1 : comparemela.com

Nuvation Bio Inc. (NYSE:NUVB) Director Acquires $499,348.10 in Stock

Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) Director Kim D. Blickenstaff purchased 172,189 shares of the company’s stock in a transaction on Tuesday, June 11th. The stock was purchased at an average cost of $2.90 per share, for a total transaction of $499,348.10. Following the purchase, the director now directly owns 172,189 shares in […]

Weekly Analysts' Ratings Updates for Nuvation Bio (NUVB)

Nuvation Bio (NYSE: NUVB) recently received a number of ratings updates from brokerages and research firms: 6/3/2024 – Nuvation Bio had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock. 5/24/2024 – Nuvation Bio had its “outperform” rating reaffirmed by analysts at Wedbush. They now […]

Nuvation Bio (NYSE:NUVB) Shares Down 7.7%

Nuvation Bio Inc. (NYSE:NUVB – Get Free Report)’s share price fell 7.7% on Monday . The company traded as low as $2.85 and last traded at $2.86. 677,357 shares were traded during mid-day trading, a decline of 44% from the average session volume of 1,220,003 shares. The stock had previously closed at $3.10. Analyst Upgrades […]

Nuvation Bio (NYSE:NUVB) Shares Down 7.7%

Nuvation Bio Inc. (NYSE:NUVB – Get Free Report)’s share price fell 7.7% on Monday . The company traded as low as $2.85 and last traded at $2.86. 677,357 shares were traded during mid-day trading, a decline of 44% from the average session volume of 1,220,003 shares. The stock had previously closed at $3.10. Analyst Upgrades […]

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting